Basel Medical Group (BMGL) director Paul Freudenthaler files initial Form 3

Rhea-AI Filing Summary

Basel Medical Group Ltd director Paul D. Freudenthaler filed an initial ownership report on Form 3. This filing identifies him as a director of the company but does not list any specific share transactions or changes in ownership. It serves as a baseline disclosure of his status as an insider.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

FREUDENTHALER PAUL D

(Last) (First) (Middle)

6 NAPIER ROAD,

UNIT #02-10/11 GLENEAGLES MEDICAL CENTRE

(Street)

SINGAPORE 258499

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
02/18/2025

3. Issuer Name and Ticker or Trading Symbol
Basel Medical Group Ltd [ BMGL ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Paul Freudenthaler	03/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does the Basel Medical Group Ltd (BMGL) Form 3 filing show?

The Form 3 shows that Paul D. Freudenthaler is a director of Basel Medical Group Ltd. It is an initial insider ownership report and does not include any specific share transactions or changes in holdings.

Did Paul D. Freudenthaler buy or sell BMGL shares in this Form 3?

No. The Form 3 for Paul D. Freudenthaler lists zero buy, sell, acquire, or dispose transactions. It simply registers his status as a director and establishes a starting point for future ownership reporting.

Why is Basel Medical Group Ltd (BMGL) filing a Form 3 for this director?

Form 3 is required when someone becomes an insider, such as a director, of a public company. This filing records Paul D. Freudenthaler as a director of Basel Medical Group Ltd and sets a baseline for future Form 4 or Form 5 reports.

Does the BMGL Form 3 disclose how many shares the director owns?

The provided data do not show any specific share amounts for Paul D. Freudenthaler. The summary indicates no buy, sell, acquire, or dispose transactions, focusing instead on his role as a director of the company.

Is the Basel Medical Group Ltd (BMGL) Form 3 a trading signal?

This Form 3 is not a trading signal. It records Paul D. Freudenthaler as a director and shows no reported transactions. It functions as an initial ownership disclosure rather than evidence of buying or selling activity.